Nigerian Government Delegation Visits Leading Chinese IVD Company WIZ Biotech to Explore Localized Diagnostic Solutions for Africa
On May 26, a senior delegation from the Lagos Nigerian government visited Xiamen WIZ Biotech Co., Ltd., a prominent IVD company in China who specializes in providing point-of-care solutions, to explore strategic partnerships for the localization of diagnostic technologies in Lagos and broader African markets.
The visit was part of Lagos's ongoing effort to strengthen its healthcare system by collaborating with global leaders in infectious disease diagnostics, chronic disease monitoring, and genetic screening.
WIZ Biotech's executive team, including Chairman Mr. Lin Zhikeng, General Manager Ms. Wang Xiaozhen, and Africa Market Manager Ms. Chen Xi, hosted the visiting delegation and led a comprehensive exchange on healthcare challenges and diagnostic priorities in Lagos.
Addressing Africa's Urgent Diagnostic Needs
In-depth discussions focused on Lagos's need for affordable, high-accuracy diagnostic tests to combat major public health challenges. The Nigerian side shared insights into the high burden of fever-related illnesses, sexually transmitted infections, and non-communicable diseases, especially in rural areas lacking access to sophisticated laboratories.
In response, WIZ Biotech showcased key products aligned with these needs:
Multiplex Fever Panel Tests: Rapidly distinguish among malaria and typhoid—ideal for primary healthcare use.
Multi-pathogen Infectious Disease Panels: Detect HIV, HBV, HCV, and syphilis, as well as blood grouping in a single test.
HPV Test Kits: For cervical cancer screening, crucial in reducing women’s health disparities.
Sickle Cell Anemia PCR Test: For early genetic screening and carrier identification in high-risk populations.
A101 Analyzer for Chronic Disease Monitoring: A compact device for blood glucose and hemoglobin testing, enabling real-time management of diabetes and anemia.
WIZ Biotech emphasized its readiness to support technology transfer and local manufacturing to lower costs, improve availability, and promote diagnostic self-reliance in Nigeria.
Hands-On Technology Demonstration
The Nigerian officials participated in a guided demonstration session led by WIZ Biotech's R&D engineers. They tested real-time results using the company's fever panel rapid tests and blood glucose meters. Delegates were impressed by the 15-minute turnaround time, ease of use, and reliability—attributes essential for scalable deployment in community clinics.
The delegation also explored WIZ Biotech's broader diagnostic portfolio, which includes tumor markers, women's health panels, and COVID-19 testing solutions. Opportunities for joint clinical validation, regulatory approval pathways, and local workforce training were discussed.
“This visit represents a shared commitment to health equity,” said Chairman Lin. “As a trusted rapid test manufacturer and diagnostic test supplier for Africa, we are proud to contribute to Lagos's goal of building a resilient and accessible healthcare system.”
About WIZ Biotech
WIZ Biotech Co., Ltd. is a leading in vitro diagnostic (IVD) manufacturer based in Xiamen, China, offering a full suite of immunoassays, molecular diagnostics, and rapid test kits. With a strong global footprint, the company supports healthcare providers in over 60 countries with solutions spanning infectious disease, women’s health, chronic disease management, and genetic testing. WIZ Biotech is committed to affordable innovation, localized solutions, and public health partnerships across emerging markets.
